|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 September 2001, Vol. 98, No. 6, pp. 1645-1653
PLENARY PAPER
Dynamic molecular modeling of pathogenic mutations in the
spectrin self-association domain
Zhushan Zhang,
Scott A. Weed,
Patrick G. Gallagher, and
Jon S. Morrow
From the Departments of Pathology, Pediatrics, and
Molecular, Cellular, and Developmental Biology, Yale University, New
Haven, CT.
 |
Abstract |
Disruption of spectrin self-association underlies many inherited
hemolytic disorders. Using dynamic modeling and energy minimization, the 3-dimensional structure of the self-association domain has been
estimated in human erythrocyte spectrin and the structural consequences
of 17 elliptogenic mutations determined. The predicted structure of the
normal self-association domain was remarkably similar to the crystal
structure of the Drosophila -spectrin 14th repeat unit,
despite replacement in the human sequence of over 70% of the amino
acids relative to fly spectrin, including 2 prolines in the human
sequence that appear in helical regions of the fly structure. The
predicted structure placed all hydrophilic residues at the surface and
identified 4 salt bridges, 9 hydrophobic interactions, and 4 H-bonds
that stabilize the native self-association unit. Remarkably, every
pathologic point mutation, including seemingly conservative
substitutions such as G for A, A for V, or K for R (single-letter amino
acid codes), led to conformational rearrangements in the predicted
structure. The degree of structural disruption, as measured by
root-mean-square deviation of the predicted backbone structure from the
Drosophila structure, correlated strongly with the severity
of clinical disease associated with each mutation. This approach thus
enables an accurate prediction, from the primary sequence, of the
clinical consequences of specific point mutations in spectrin. The
3-dimensional structure of the self-association domain derived
here is likely to be accurate. It provides a powerful heuristic model
for understanding how point mutations disrupt cytoskeletal function in
a variety of hemolytic disorders.
(Blood. 2001;98:1645-1653)
© 2001 by The American Society of Hematology.
 |
Introduction |
The shape and stability of the human
erythrocyte derives from a delicately balanced surface area-volume
ratio and the lateral distribution and abundance of its integral
membrane proteins, as modified by their attachment to an underlying
spectrin-actin skeleton.1-4 Although the energetics of the
membrane may be dominated by interactions of integral proteins within
the bilayer,5 the homogeneous spectrin skeleton modifies
cell stability by modifying bilayer elasticity, by tethering or
trapping membrane proteins so as to limit their lateral diffusability
and ensure their quasi-random distribution, and by dampening the rate
of protein rearrangement during cyclic cell deformation (as occurs
during capillary passage).
One pathway by which the energetics of elasticity and membrane
protein-distribution control can be altered is by failure of the
spectrin skeleton to adequately form an anastamosing meshwork beneath
the membrane, usually due to failures in self-association. Such
disorders typically lead to asymmetrical distortions in the shape and
deformability of the red blood cell (RBC), as in various forms of
hereditary elliptocytosis (HE) (reviewed in Morrow et al,2
Tse and Lux,3 Delaunay and Dhermy,6 and
Gallagher and Jarolim7). Spectrin itself is composed of a
heterodimer of 2 structurally similar proteins, - and
-spectrin,2,8 encoded by separate
genes.9,10 Spectrin heterodimers self-associate in an
end-on fashion to form tetramers and higher order oligomers (Figure
1).11,12 This
oligomerization is critical for erythrocyte membrane stability as well
as erythrocyte shape and function. The first recognition that mutations
in spectrin that impair its ability to self-associate lead to
clinically significant forms of HE and hereditary pyropoikilocytosis
(HPP) came from the study of a small family with 2 severely
afflicted siblings who displayed bizarre misshapen RBCs (poikilocytes),
and with an older sibling and mother who displayed less severe disease
with elliptocytic RBCs.13,14 Subsequent studies in many
laboratories examining other patients with HE and HPP have identified a
number of hereditary conditions characterized by point mutations that
reduce the self-association ability of spectrin.

View larger version (43K):
[in this window]
[in a new window]
| Figure 1.
Cartoon of the self-association site of spectrin.
The self-association site is formed by a contribution of one helix from
the amino-terminus of -spectrin, and 2 helices from the incomplete
17th repeat unit near the COOH-terminus of -spectrin.
|
|
Although the realization that point mutations in spectrin can cause
hemolytic disease opened a new era of understanding and nosology of
these disorders,15 there has been little progress in
understanding how such mutations actually perturb the function of
spectrin. Insightful analyses based on the complete sequence of
spectrin revealed that spectrin is composed of repeats of 106 amino
acids, and suggested that these repeats fold into -helical, coiled-coil triple helices.9,10,16 In these putative
repeats, the first and third helices were envisioned to be parallel and the second helix antiparallel. Support for this model has been provided
by x-ray, nuclear magnetic resonance (NMR), and spectroscopic studies
of spectrin.17-23 The spectrin triple helical repeats are amphipathic and stabilized by the sequestration of the hydrophobic faces of each helix along the interior of the repeat bundle. Phasing of
the repeats revealed that there are incomplete repeats at the NH2-terminus of -spectrin and the COOH-terminus of
-spectrin (by 1 and 2 helices, respectively). When a point mutation
was identified in the COOH-terminal partial repeat of -spectrin from an HE/HPP kindred with severe anemia and impaired spectrin
self-association, it was postulated that the self-association site in
spectrin must be formed from an atypical triple helical unit involving
the interaction of the COOH-terminus of -spectrin (helices A and B)
and the NH2-terminus of -spectrin (helix C) (Figure 1,
bottom).24 Additional studies have identified over 20 mutations associated with HE or HPP in this atypical triple helical
unit that are defective in spectrin self-association (Table
1). Other work detected further
correlations between the clinical HE/HPP phenotype and the presence of
mutations in this putative triple helical unit.6,25
Studies examining directly the self-association activity of spectrin
using recombinant peptides also came to a similar
conclusion,26-29 and have demonstrated that this atypical
repeat forms the critical region of the spectrin self-association site.
Despite these advances, the challenge of understanding in detail
the structure of the spectrin self-association domain remains. Given
the lability and low-affinity of this noncovalent interaction (Ka 10 µM), the direct resolution of its structure by
either multidimensional NMR or crystallography is a daunting challenge. As an alternative, we have explored the power of computational strategies to develop plausible models of this dynamic structure. These
efforts involve the conceptual folding of 2 peptide sequences representing the self-association domains of - and
-spectrin.26,27 This modeling seeks to minimize the
total system energy derived from all backbone and side-chain
interactions, including interactions with a surrounding hydration
shell. Dynamic modeling is used to facilitate the refinement of the
structure and to relieve forbidden steric or angular dependencies. The
resultant structures are triple helical, and for wild-type sequences
are closely similar to the crystal structures of a single spectrin
repeat unit. Interestingly, we find that even ostensibly conservative
single residue replacements can significantly destabilize the predicted
structure, with the degree of destabilization closely paralleling the
clinical severity associated with each mutation.
 |
Materials and methods |
Molecular modeling
Programs used to calculate the total system energy of different
conformations, and to present the resultant structures as 3-dimensional
representations, included X-plor, version 3.1m,31 and the
program Insight32; both were operated on a Silicon Graphics Indigo2 Extreme workstation. The starting structure for the modeling was that portion of the crystal structure of
Drosophila spectrin that represents a single repeat
unit.17 The 2-repeat triple helical crystal structure of
chicken -spectrin23 was also considered as a starting
point for the modeling determinations, but was deemed to be less
suitable because it shared a backbone structure that was almost
indistinguishable from the fly (root-mean-square deviation
[RMS ] = 1.98 Å); was less well resolved relative to the fly
structure (2.0 Å versus 1.8 Å); and surprisingly, shared less primary
sequence homology with the putative human self-association domain than
did the Drosophila sequence (25%-30% homology for avian
spectrin versus 33% for the fly 14th repeat). No attempts were made to
model a structure based on the alternatively phased conformation of the
avian 2-repeat structure,23 because this conformation was
deemed to be an unlikely candidate given the absence of covalent
continuity between the putative B and C helices of the self-association
site (see below), continuity that would a priori appear to
be a prerequisite to extend the B helix at the expense of the C helix
in this conformation. To establish the validity of the modeling
simulations and to explore the parameters needed to achieve a
creditable approximation, the structure of the Drosophila
-spectrin 14th structural repeat itself was modeled and compared
with its crystal structure. The molecular dynamics at 300°K of the
Drosophila -spectrin 14th repeat were initially modeled
in a vacuum, using the Verlet method.33 This approach yielded helices at the NH2- and COOH-termini that unwound
excessively, and the orientation of the amino acid side chains were
dissimilar to the crystal structure. This same result was obtained when
a simulated annealing starting at high temperature was used. These results suggested that simulation in a vacuum was inappropriate for
this super helix of the 3 helices, and suggested that interactions between spectrin and the aqueous environment were critical to its
structure. To solve this problem, and given practical limitations on
the computational complexity that could be managed, the effects of
modeling this structure in a 6-Å water shell using both molecular dynamics at 300°K and simulated annealing from high temperatures were
evaluated. The starting structure was "placed" in a 6-Å-thick water shell that contained about 1100 water molecules. Five hundred steps of Powell conjugate gradient energy minimization34
were first performed to minimize the system energy. Then Verlet
molecular dynamics was used to accomplish the simulated annealing. The
simulated temperature was raised to 1000°K, and then cooled to
110°K in steps of 10°K. At each temperature, 400 time-steps of
dynamic calculation were performed. Time-step increments
(TSk) were determined by the following
formula:
The total simulation time was 16.5 picoseconds (ps). The initial
velocity was randomly set according the Maxwell velocity distribution.
The frictional coefficient was set to 100 ps 1 for all
atoms. A structure was sampled after each temperature step. The 90 sampled structures were energy minimized by the Powell conjugate
gradient energy minimization with 2000 steps, and the 10 structures
with lowest energy minima were averaged. Energy minimization was then
again performed on the averaged structure with 2000 steps. The
tolerance for the norm of the gradient of Etotal was 0.01 during all of the energy minimization procedures. This approach yielded
better agreement with the known crystal structure (described below and
Figure 2).

View larger version (32K):
[in this window]
[in a new window]
| Figure 2.
The self-association domain of spectrin can be modeled as a triple
helix.
(Top) Alignment of the primary sequence of Drosophila
-spectrin 14th unit with the partial repeat units from the
amino-terminus of human I-spectrin (residues 19-51) and from the
17th repeat unit of I-spectrin (residues 2008-2080), using the
program Bestfit.35 The position of the 3 helices as
determined from the crystal structure of the Drosophila
spectrin are shown. Continuity was not assumed where the 2 subunits
join in the concatenated sequence. This concatenated sequence, with or
without the mutations described in the text, was then treated as a
pseudo-106 residue repeat unit for the dynamic modeling studies. Dros
indicates Drosophila; term, terminus. (Bottom) Comparison of
the calculated structure of Drosophila -spectrin 14th
repeat (blue) or the concatenated human I I self-association
domain (green) with the crystal structure of the Drosophila
14th repeat (red). Two views are shown, longitudinal on the left, and
an end-on view on the right. The 6-Å hydration shell involving 1100 water molecules is not shown. This hydration shell is required for the
predicted structure to fold to a triple-helical unit. Note the close
correspondence of the fitted structures with the crystal, even though
in the case of the self-association domain, 70% of the residues differ
from those in the Drosophila protein.
|
|
Alignment of the structural unit with the self-association
domain
For purposes of molecular modeling, the self-association domain
of I I spectrin was evaluated as a single concatenated
sequence. To approximate the positioning of the putative triple helical self-association unit relative to the Drosophila structural
repeat, the sequence of the self-association unit of
I I-spectrin was aligned with the 14th repeat unit of
Drosophila -spectrin using the program
BestFit35 (Figure 2, top). The corresponding residues of
human spectrin were then graphically incorporated into the published
crystallographic coordinates of fly spectrin, thereby creating a
starting structure for the dynamic modeling computations. Residues 1 to 73 of the chain in the Drosophila crystal
structure were replaced with the partial 17th structural unit of
I-spectrin. Residues 74 to 106 of the crystal structure were
replaced with the extended amino-terminus of I-spectrin. A pseudo
repeat unit with a continuous peptide chain was thus generated for use
in the modeling calculations (although to faithfully reflect the native
state, the calculations did not assume continuity between the - and
-spectrin concatenated sequences). A total of 73 residues were
substituted relative to the Drosophila sequence for the
wild-type self-association domain, and 72 + 1 (mutant) residues for
each mutant examined. Replaced structures were used as the starting structure for the molecular modeling algorithms. It is noteworthy that many of the replaced residues even in the wild-type spectrin represent nonconservative substitutions relative to the
Drosophila sequence, including the inclusion of a proline
residue in the middle of helix C. Yet, and despite these many
substitutions, the modeling algorithms converged on a predicted
structure for the normal human self-association domain that was
remarkably similar in its overall structural features to the
Drosophila structure unit (Figure 2, bottom).
Determination of side-chain interactions
Salt-bridge interactions and hydrophobic interactions between
residues were scored as positive if they fell within 5 Å of each other
in the refined structure. Hydrogen bonds were scored as present if the
distance between the electronegative atoms (N & O) within O-H-N or
O-H-O groups were 2.9 Å apart.
Evaluation of clinical severity
In evaluating the clinical impact of each spectrin mutation,
consideration was given to the degree of hemolysis or RBC cell fragility, steady-state hemoglobin or hematocrit (in nontransfused subjects), the reticulocyte count, transfusion dependency, whether splenectomy had been necessary, the degree of morphologic abnormality, and the overall morbidity and mortality. These parameters were extracted from clinical data described in the original reports (Table
1). Patients with no abnormalities in erythrocyte shape or stability
were scored 0; shape abnormalities without evidence of hemolysis or
clinical disease were +1; mild hemolysis but not requiring splenectomy,
+2; severe hemolysis with or without splenectomy, possibly lethal in
homozygous state, +3; and the most severe disease, transfusion
dependent, always lethal in homozygotes, +4.
 |
Results |
Molecular modeling predicts a plausible model of the spectrin
self-association domain
The simulated structure of the 14th structural unit of
Drosophila -spectrin derived by this method was
superimposed onto its crystal structure (Figure 2, bottom). As noted in
a previous study using a similar approach,36 the predicted
structure, including the orientation of the side chains, agrees well
with the crystal structure. The RMS for the comparison between the
crystal structure and that estimated by the above modeling procedure
for Drosophila -spectrin was 1.99 Å for the backbone
atoms and 2.42 Å for all heavy atoms. Overall, the calculated
structure is a bit less compact compared to the crystal structure. It
is not known if this small difference represents errors in the
computational approximation or a real difference in compactness between
the solution structure and that of the crystal (which is prepared but
not modeled in a high-salt environment).
The predicted structure for the normal spectrin self-association domain
is also similar to the structure of the Drosophila repeat,
with a backbone RMS of just 2.846Å (Figure 2). This is a
satisfactory result, given that over 70% of the structure has been
replaced with different amino acids, including 2 proline residues at
positions 23 in helix A and 64 in helix B ( -spectrin residues 2030 and 2071, respectively). It is also important to note that the
similarity of the predicted normal human self-association unit to the
Drosophila structural repeat is unlikely to reflect an
insensitivity of the modeling algorithms to the variant sequences, because as demonstrated below, single residue replacements that are
known to affect the function of the self-association domain have a
profound effect on the predicted structure.
Interactions of helix C with helices A and B primarily stabilize
the self-association unit
Based on the plausibility of the predicted overall tertiary and
quaternary structure of the self-association unit, an analysis was
carried out to identify interactions predicted to maximally stabilize
the functional unit (as described in "Materials and methods").
Three types of linkages were evaluated: hydrophobic interactions
involving nonpolar side chains; hydrogen bonds, and ionic charge
interactions (salt bridges). These results are summarized in Figure
3 and Table
2. Interestingly, most of the putative strong interactions identified in the modeled structure involve helix C
interacting with helix A or B. Just 2 direct interactions were
predicted between helices A and B, and one of these is marginal (internuclear distance > 5 Å), suggesting that in the absence of a
third helix (ie, the helix provided by -spectrin), the
self-association domain probably exists in a more open conformation
with its 2 helices at least partially extended. This prediction is
consonant with the intermediate open state identified in studies
examining the protease-resistant structure of
-spectrin.26

View larger version (81K):
[in this window]
[in a new window]
| Figure 3.
Helical wheel depiction of the self-association unit.
The predicted structure of the normal spectrin self-association unit
was examined for the presence of various types of noncovalent
interactions, based on their chemical characteristics and proximity.
These interactions are depicted and are summarized in Table 2. Note
that nearly all of the interactions stabilizing the triple helical
self-association unit arise between helix A or B with helix C. One
interaction between helix A and B involves a salt bridge with R2079
(labeled), which falls in the loop sequence between helix B and C. Helices A and B are derived from -spectrin (shaded), helix C from
-spectrin.
|
|
Mutations of - and -spectrin destabilize the
self-association domain
Spectrin Providence was first identified in a family with
recurrent fatal erythroblastosis fetalis. The cause was traced to a P
for S (single-letter amino acid codes) mutation at codon 2019 of
-spectrin. This residue falls in the middle of helix A. In the
heterozygous state, these patients display elliptocytosis and marked
erythrocyte fragility. Biochemical studies have established a
substantial loss of self-association ability in this spectrin mutation.
The predicted structural consequences of this mutation are profound
(Figure 4, top, and Figure
5). This single amino acid mutation
leads the modeling algorithms to predict a markedly disrupted tertiary
structure, with a splaying of helices A and B, and a loss of the narrow
pocket into which helix C ( -spectrin) normally docks. Based on this
predicted structure, it is hard to imagine how an effective
self-association interaction could be achieved. These results fit well
the measured self-association constant for this spectrin, which is more
than 2 logs weaker than for normal spectrin.37 The severe
disruption of the self-association domain that follows the Providence
mutation can be better appreciated in the stereo presentation
(Figure 5).

View larger version (42K):
[in this window]
[in a new window]
| Figure 4.
Mutations of - and
-spectrin disrupt the normal predicted structure of the spectrin
self-association domain.
(Top pair) Structure of normal spectrin versus spectrin
Providence, showing the position of the S P amino acid
replacement at codon 2019 (position 12 in the A helix). Note the
predicted severe distortion of this helix, with loss of the
-spectrin pocket into which -spectrin (helix C) docks. (Bottom
pair) A similar analysis revealing the predicted effect of a mutation
in codon 28 of -spectrin (R28S), a mutation that leads to hereditary
pyropoikilocytosis. Even though the serine in this mutation is
hydrophilic like the residue it replaces (R), the loss of the 2 putative salt bridges formed by the lost arginine (Table 2)
destabilizes the self-association binding site. In each model,
longitudinal and end-on views are shown. The mutated residue is
depicted in space-filled form.
|
|

View larger version (40K):
[in this window]
[in a new window]
| Figure 5.
Stereo drawing of the spectrin Providence mutation.
(A) Predicted structure of the normal self-association unit. (B)
Predicted structure of the self-association unit in spectrin
Providence. This spectrin mutation leads to severe hemolytic disease
and erythroblastosis fetalis in the homozygous
state.37
|
|
Another site of mutation that commonly causes hemolytic disease is at
codon 28 of I-spectrin (Table 1). The predicted structure of
spectrin with an R S mutation at this locus is shown (Figure 4,
bottom). Given that both S and R are hydrophilic, it is surprising that
this substitution would have such dramatic structural consequences. Similarly, spectrin Corbeil, an R H mutation at this locus, is also
associated with significant poikilocytic hemolytic anemia and defective
spectrin self-association.38 The model of spectrin Corbeil
(Figure 6) also predicts major
conformational changes. Given that 28 is the codon most commonly
mutated in HE and HPP, it is gratifying that these modeling studies
reveal it to be critical for maintaining the secondary, tertiary, and
quaternary structure of the self-association unit. Indeed, even
ostensibly conservative substitutions at this locus (such as R H) are
disruptive. Presumably, this sensitivity reflects the requirement for
the 2 hydrogen bonds formed between R28 and residues 2018 and 2022 of
-spectrin.

View larger version (48K):
[in this window]
[in a new window]
| Figure 6.
Modeling of 17 pathogenic mutations in the spectrin self-association domain.
(A) Mutations involving I-spectrin. (B) Mutations involving
I-spectrin. Note the predicted disruption, sometimes severe, that
accompanies the substitution of even a single native residue.
Longitudinal and end-on views are shown for each mutation. The mutated
residue is depicted in each case using a solid-filled representation.
The coordinates for each of these modeled structures are available as
.PDB files (downloadable as .RTF files) on the Blood website
as supplemental material; see the Supplemental Data Sets link at the
top of the online article.
|
|
All pathogenic mutations disrupt the predicted tertiary
structure of the self-association domain
To establish the generality and predictive value of the
modeling algorithm, 17 different mutations involving either the - or
-subunit of spectrin were modeled. All of these mutations have been
identified because they generate a detectable phenotype. The severity
of these phenotypes ranges from severe and often fatal hemolytic
anemias or erythroblastosis fetalis to minor disturbances in
erythrocyte shape without measurable disturbances in stability. These
mutations are summarized in Table 1, and the derived structures are
shown in Figure 6. It is apparent that for all pathologic mutations,
there is some disruption of the secondary, tertiary, and quaternary
structure. The RMS values of these structures relative to the
crystal structure of Drosophila -spectrin range from a
value equivalent to the native structure (K28R I-spectrin) to the
markedly deviant structure predicted for the R28L mutation in
I-spectrin.
Molecular modeling correlates well with the clinical severity of
each mutation
When the degree of predicted disruption in the structure of the
self-association unit, as measured by the RMS of its predicted backbone structure versus the Drosophila crystal structure,
is compared to the approximate clinical severity of patients carrying the mutation, a striking correlation emerges (Figure
7). Although this correlation must of
necessity be only approximate, given the clinical heterogeneity
observed for any given mutation even within the same family (eg, due to
the presence of a low expression spectrin allele in cis or
trans),39 these findings strongly imply that
the structural changes anticipated by the modeling algorithms are
directly reflected in the functional integrity of the
self-association domain.

View larger version (16K):
[in this window]
[in a new window]
| Figure 7.
The degree of predicted structural disruption correlates
well with the clinical severity induced by the mutation.
For each of the 17 mutations in the self-association domain that were
modeled (Table 1), the RMS of their backbone structure versus that
of the Drosophila crystal structure was plotted versus an
estimate of the clinical severity of the condition, on a scale of 0 to
4 (as described in "Materials and methods"). Also included in this
plot is the RMS value for the native structure (2.846 Å, clinical
severity = 0). Note that the deviation of the mutant structures, as
predicted by dynamic molecular modeling from a knowledge of the primary
sequence and the crystal structure of Drosophila spectrin,
correlates well with the clinical severity of each mutation. This
behavior can be approximated by the equation shown, derived by a
nonlinear least squares fit to the data.
|
|
 |
Discussion |
The results presented here establish a computational approach for
generating plausible models of the spectrin self-association domain and
for predicting the structural consequences of point mutations involving
this domain in either - or -spectrin. This conclusion is
supported by several observations: (1) modeling the
Drosophila -spectrin 14th repeat unit accurately reflects its structure as measured by x-ray crystallography; (2) the predicted structure of the self-association domain of normal spectrin is very
similar to the Drosophila structure, and valid in comparison to criteria set by other studies.17,23 This is so despite
the replacement of over 70% of its residues, including 2 proline
substitutions present in the human but not the Drosophila
sequence, a conclusion consonant with the well-recognized conservation
across broad evolutionary distances of secondary and tertiary
structural features within a given protein family; and (3) the
plausibility of the predicted structure itself, with polar residues on
the surface, hydrophobic residues buried, an absence of steric
conflicts, and a satisfactory number and variety of stabilizing
noncovalent interactions.
Given the presumed validity of this model, what does it tell us about
spectrin? Perhaps the most profound lesson, beyond refining by more
rigorous analysis earlier concepts of the structure of the
self-association domain, is that the tertiary and quaternary structure
of the spectrin repeat may be precariously balanced between multiple
conformational states. Several biophysical studies have noted
conformational transitions in spectrin at physiologic temperatures,20 that its protease resistance is extremely
sensitive to temperature and ionic strength,40 and that
alternative folding states exist that might account for spectrin's
unusual hydrodynamic properties.23 Yet, none of these
studies would have predicted such profound sensitivity of the spectrin
repeat unit and self-association unit to even seemingly minor residue substitutions.
These results also extend our understanding of the many hemolytic
disorders caused by defective spectrin self-association. The majority
of patients with HE and HPP have mutations in the region of
- -spectrin self-association.7,41 Heterozygous point
mutations in the -spectrin self-association site (helix C) are among
the most common mutations identified in patients with HE or HPP (Table
1). Homozygous patients with such point mutations have not been
described, perhaps because the complete loss of spectrin
self-association may be incompatible with life. Point mutations in the
-spectrin self-association site are generally mild in the
heterozygous state and severe, even fatal, in the homozygous state.
Truncations that remove all or part of the COOH-terminal region of
-spectrin in the heterozygous state are associated with symptomatic
elliptocytosis with poikilocytes and fragmented erythrocytes. As with
homozygous -spectrin self-association site mutants, homozygotes with
truncated -spectrin have not been observed.7 With the
insights gained in this study into the forces that stabilize the
self-association unit (Table 2 and Figure 3), these clinical observations can now be better understood.
As noted above, residue 28 of -spectrin (Table 1) appears to be a
"hot spot" for point mutations associated with variable clinical
manifestations and is never found in the homozygous state. From
molecular modeling, we see that mutations at this locus are predicted
to disrupt 2 important hydrogen bonds between this residue and residues
2018 and 2022 of -spectrin, resulting in a failure of helix C
( -spectrin) to properly dock in the -spectrin pocket. Correspondingly, when the -spectrin 2018 residue is mutated, as it
is in spectrin Cagliari, a similar phenotype results.
An example of a mutation in the -spectrin self-association domain
that is either fatal or associated with a severe, transfusion-dependent hemolytic anemia is spectrin Buffalo, with an R L substitution at
residue 2025.42 Dynamic modeling of the spectrin
Buffalo mutation predicts that hydrophobic interactions in the interior of the triple helical repeat are disrupted by the replacement of the
hydrophobic uncharged leucine with a hydrophilic positively charged
arginine (Figure 6; also Gallagher et al42). Another example is spectrin Providence, also fatal in the homozygous state, with a P S substitution at residue 2019.37 This residue
is adjacent to the critical hydrogen bond that stabilizes the
self-association unit, noted above between 28 and 2018. Modeling
demonstrates that the spectrin Providence mutation significantly
disrupts the forces that stabilize the -spectrin pocket (helices A
and B) into which -spectrin (helix C) docks (Figures 4 and 5).
In summary, these results provide important information on the putative
interactions between specific amino acid residues that compose the
self-association unit of human I I-spectrin, and highlight the
extraordinary sensitivity of the self-association unit to disruption by
the single point mutations that are associated with clinical disorders
of erythrocyte shape or stability. These data also allow a prediction
of the specific residues whose disruption is likely to lead to a
clinical phenotype. For example, in -spectrin, 11 residues likely to
be critical to the structure of the self-association unit have been
identified by this computational approach. Mutations have been
discovered in, or immediately adjacent to, 8 of these 11 residues. On
this basis and on the strength of our model, we predict that clinically
significant mutations involving the other 3 critical -spectrin
residues ( 31, 38, and 43), or residues immediately adjacent,
await discovery. A final lesson to come from this work is the clear
demonstration that a complex clinical syndrome, and its severity, can
be predicted essentially from first principles (ie, only with knowledge
of the primary peptide sequence and a starting approximation of its
structure). To our understanding, this represents perhaps the first
time that such a precise correlation has been possible for these types
of cytoskeletal disorders, and suggests that this approach may be
valuable for predicting the consequences of mutations in other
functional domains of spectrin, and potentially for other proteins as well.
 |
Acknowledgments |
Drs Scott Kennedy, Carol Cianci, and Bernard Forget are thanked for
their many helpful insights and assistance with various aspects of this project.
 |
Footnotes |
Submitted March 2, 2001; accepted May 14, 2001.
Supported by a grant from the March of Dimes Birth Defects Foundation
(to P.G.G.) and by grants from the National Institutes of Health (to
P.G.G. and J.S.M.).
Portions of these results have been previously presented in abstract
form at the 1999 FASEB meeting.30
The publication costs of this
article were defrayed in part by
page charge payment. Therefore,
and solely to indicate this fact,
this article is hereby marked
"advertisement"
in accordance with 18 U.S.C.
section 1734.
Reprints: Jon S. Morrow, Department of Pathology, Yale
University, 310 Cedar St, New Haven, CT 06510; e-mail:
jon.morrow{at}yale.edu.
 |
References |
1.
De Matteis MA, Morrow JS.
Spectrin tethers and mesh in the biosynthetic pathway.
J Cell Sci.
2000;113:2331-2343[Abstract].
2.
Morrow JS, Rimm DL, Kennedy SP, Cianci CD, Sinard JH, Weed SA.
Of membrane stability and mosaics: the spectrin cytoskeleton. In:
Hoffman J,Jamieson J, eds.
Handbook of Physiology. London, UK: Oxford; 1997:485-540.
3.
Tse WT, Lux SE.
Red blood cell membrane disorders.
Br J Haematol.
1999;104:2-13[CrossRef][Medline]
[Order article via Infotrieve].
4.
Corbett JD, Agre P, Palek J, Golan DE.
Differential control of band 3 lateral and rotational mobility in intact red cells.
J Clin Invest.
1994;94:683-688.
5.
Mohandas N, Evans E.
Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects.
Annu Rev Biophys Biomol Struct.
1994;23:787-818[Medline]
[Order article via Infotrieve].
6.
Delaunay J, Dhermy D.
Mutations involving the spectrin heterodimer contact site: clinical expression and alterations in specific function.
Semin Hematol.
1993;30:21-33[Medline]
[Order article via Infotrieve].
7.
Gallagher PG, Jarolim P.
Red cell membrane disorders. In:
Hoffman R,Benz EJ Jr,Shattil SJ, et al., eds.
Hematology: Basic Principles and Practice. 3rd ed. New York, NY: Churchill Livingstone; 2000:576-610.
8.
Winkelmann JC, Forget BG.
Erythroid and non-erythroid spectrins.
Blood.
1993;81:3173-3185[Abstract/Free Full Text].
9.
Sahr KE, Laurila P, Kotula L, et al.
The complete cDNA and polypeptide sequences of human erythroid -spectrin.
J Biol Chem.
1990;265:4434-4443[Abstract/Free Full Text].
10.
Winkelmann JC, Chang JG, Tse WT, Scarpa AL, Marchesi VT, Forget BG.
Full-length sequence of the cDNA for human erythroid beta-spectrin.
J Biol Chem.
1990;265:11827-11832[Abstract/Free Full Text].
11.
Morrow JS, Speicher DW, Knowles WJ, Hsu CJ, Marchesi VT.
Identification of functional domains of human erythrocyte spectrin.
Proc Nat Acad Sci U S A.
1980;77:6592-6596[Abstract/Free Full Text].
12.
Morrow JS, Marchesi VT.
Self-assembly of spectrin oligomers in vitro: a basis for a dynamic cytoskeleton.
J Cell Biol.
1981;88:463-468[Abstract/Free Full Text].
13.
Knowles WJ, Morrow JS, Speicher DW, et al.
Spectrin from patients with hereditary pyropoikilocytosis have self-association defects and an abnormal tryptic digestion map. ICN/UCLA Symposium on Differentiation and Function of Hematopoietic Cell Surfaces Keystone, CO: February; 1981.
14.
Knowles WJ, Morrow JS, Speicher DW, et al.
Molecular and functional changes in spectrin from patients with hereditary pyropoikilocytosis.
J Clin Invest.
1983;71:1867-1877.
15.
Lux SE, Palek J.
Disorders of the red cell membrane. In:
Handin RI,Lux SE,Stossel TP, eds.
Blood: Principles and Practice of Hematology. Philadelphia, PA: Lippincott; 1995:1701-1816.
16.
Speicher DW, Marchesi VT.
Erythrocyte spectrin is comprised of many homologous triple helical segments.
Nature (London).
1984;311:177-180[CrossRef][Medline]
[Order article via Infotrieve].
17.
Yan Y, Winograd E, Viel A, Cronin T, Harrison SC, Branton D.
Crystal structure of the repetitive segments of spectrin.
Science.
1993;262:2027-2030[Abstract/Free Full Text].
18.
Pascual J, Pfuhl M, Rivas G, Pastore A, Saraste M.
The spectrin repeat folds into a three-helix bundle in solution.
FEBS Lett.
1996;383:201-207[CrossRef][Medline]
[Order article via Infotrieve].
19.
Pascual J, Pfuhl M, Walther D, Saraste M, Nilges M.
Solution structure of the spectrin repeat: a left-handed antiparallel triple-helical coiled-coil.
J Mol Biol.
1997;273:740-751[CrossRef][Medline]
[Order article via Infotrieve].
20.
Ralston GB, Dunbar JC.
Salt and temperature-dependent conformation changes in spectrin from human erythrocyte membranes.
Biochim Biophys Acta.
1979;579:20-30[Medline]
[Order article via Infotrieve].
21.
Calvert R, Ungewickell E, Gratzer W.
A conformational study of human spectrin.
Eur J Biochem.
1980;107:363-367[Medline]
[Order article via Infotrieve].
22.
LaBrake CC, Wang L, Keiderling TA, Fung LW.
Fourier transform infrared spectroscopic studies of the secondary structure of spectrin under different ionic strengths.
Biochemistry.
1993;32:10296-10302[CrossRef][Medline]
[Order article via Infotrieve].
23.
Grum VL, Li D, MacDonald RI, Mondragon A.
Structures of two repeats of spectrin suggest models of flexibility.
Cell.
1999;98:523-535[CrossRef][Medline]
[Order article via Infotrieve].
24.
Tse WT, Lecomte MC, Costa FF, et al.
Point mutation in the beta-spectrin gene associated with alpha I/74 hereditary elliptocytosis: implications for the mechanism of spectrin dimer self-association.
J Clin Invest.
1990;86:909-916.
25.
Nicolas G, Pedroni S, Fournier C, et al.
Spectrin self-association site: characterization and study of beta-spectrin mutations associated with hereditary elliptocytosis.
Biochem J.
1998;332:81-89.
26.
Speicher DW, DeSilva TM, Speicher KD, Ursitti JA, Hembach P, Weglarz L.
Location of the human red cell spectrin tetramer binding site and detection of a related "closed" hairpin loop dimer using proteolytic footprinting.
J Biol Chem.
1993;268:4227-4235[Abstract/Free Full Text].
27.
Kennedy SP, Weed SA, Forget BG, Morrow JS.
A partial structural repeat forms the heterodimer self-association site of all -spectrins.
J Biol Chem.
1994;269:11400-11408[Abstract/Free Full Text].
28.
Cherry L, Menhart N, Fung LW.
Interactions of the alpha-spectrin N-terminal region with beta-spectrin: implications for the spectrin tetramerization reaction.
J Biol Chem.
1999;274:2077-2084[Abstract/Free Full Text].
29.
Lecomte MC, Nicolas G, Dhermy D, Pinder JC, Gratzer WB.
Properties of normal and mutant polypeptide fragments from the dimer self-association sites of human red cell spectrin.
Eur Biophys J.
1999;28:208-215[CrossRef][Medline]
[Order article via Infotrieve].
30.
Zhang Z, Weed SA, Morrow JS.
Dynamic molecular modeling of pathogenic mutations in the spectrin self-association domain [abstract].
FASEB J.
1999;13:A1394.
31.
Brünger AT.
X-Plor: A system for x-ray crystallography and NMR (ed X-plor pre-release version 3.851, available via the Internet [1996]). New Haven, CT: Yale University Press; 1992.
32.
Biosym Technologies.
Insight II User guide ed 2.3.0; 1993.
33.
Verlet L.
Computer experiments on classical fluid, I: thermodynamical properties of Lennard-Jones molecules.
Physical Rev.
1967;159:98-103[CrossRef].
34.
Powell MJD.
Restart procedures for the conjugate gradient method.
Mathematical Programming.
1977;12:141-254[CrossRef].
35.
Devereux J, Haeberli P, Smithies O.
A comprehensive set of sequence analysis programs for the VAX.
Nucleic Acids Res.
1984;12:387-395.
36.
Stabach PR, Cianci CD, Glantz SB, Zhang Z, Morrow JS.
Site-directed mutagenesis of II spectrin (fodrin) reveals determinants of its µ-calpain susceptibility.
Biochemistry.
1997;36:57-65[CrossRef][Medline]
[Order article via Infotrieve].
37.
Gallagher PG, Weed SA, Tse WT, et al.
Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene [see comments].
J Clin Invest.
1995;95:1174-1182.
38.
Garbarz M, Lecomte MC, Feo C, et al.
Hereditary pyropoikilocytosis and elliptocytosis in a white French family with the spectrin alpha I/74 variant related to a CGT to CAT codon change (Arg to His) at position 22 of the spectrin alpha I domain.
Blood.
1990;75:1691-1698[Abstract/Free Full Text].
39.
Wilmotte R, Marechal J, Morle L, et al.
Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46.
J Clin Invest.
1993;91:2091-2096.
40.
Speicher DW, Morrow JS, Knowles WJ, Marchesi VT.
Identification of proteolytically resistant domains of human erythrocyte spectrin.
Proc Natl Acad Sci U S A.
1980;77:5673-5677[Abstract/Free Full Text].
41.
Gallagher PG, Forget BG.
Hematologically important mutations: spectrin variants in hereditary elliptocytosis and hereditary pyropoikilocytosis.
Blood Cells Mol Dis.
1996;22:254-258[CrossRef][Medline]
[Order article via Infotrieve].
42.
Gallagher PG, Petruzzi MJ, Weed SA, Zhang Z, Marchesi SL, Mohandas N, Morrow JS, Forget BG.
Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia.
J Clin Invest.
1997;99:267-277[Medline]
[Order article via Infotrieve].
43.
Sahr KE, Coetzer TL, Moy LS, et al.
Spectin Cagliari: an Ala Gly substitution in helix 1 of beta spectrin repeat 17 that severely disrupts the structure and self-association of the erythrocyte spectrin heterodimer.
J Biol Chem.
1993;268:22656-22662[Abstract/Free Full Text].
44.
Parquet N, Devaux I, Boulanger L, et al.
Identification of three novel spectrin alpha I/74 mutations in hereditary elliptocytosis: further support for a triple-stranded folding unit model of the spectrin heterodimer contact site.
Blood.
1994;84:303-308[Abstract/Free Full Text].
45.
Glele-Kakai C, Garbarz M, Lecomte MC, et al.
Epidemiological studies of spectrin mutations related to hereditary elliptocytosis and spectrin polymorphisms in Benin.
Br J Haematol.
1996;95:57-66[CrossRef][Medline]
[Order article via Infotrieve].
46.
Qualtieri A, Pasqua A, Bisconte MG, Le Pera M, Brancati C.
Spectrin Cosenza: a novel beta chain variant associated with Sp alphaI/74 hereditary elliptocytosis.
Br J Haematol.
1997;97:273-278[CrossRef][Medline]
[Order article via Infotrieve].
47.
Baklouti F, Marechal J, Morle L, et al.
Occurrence of the alpha I 22 Arg His (CGT CAT) spectrin mutation in Tunisia: potential association with severe elliptocytosis.
Br J Haematol.
1991;78:108-113[Medline]
[Order article via Infotrieve].
48.
Coetzer TL, Sahr K, Prchal J, et al.
Four different mutations in codon 28 alpha spectrin are associated with structurally and functionally abnormal spectrin alphaI/74 in hereditary elliptocytosis.
J Clin Invest.
1991;88:743-749.
49.
Randon J, Boulanger L, Marechal J, et al.
A variant of spectrin low-expression allele alpha LELY carrying a hereditary elliptocytosis mutation in codon 28.
Br J Haematol.
1994;88:534-540[Medline]
[Order article via Infotrieve].
50.
Floyd PB, Gallagher PG, Valentino LA, Davis M, Marchesi SL, Forget BG.
Heterogeneity of the molecular basis of hereditary pyropoikilocytosis and hereditary elliptocytosis associated with increased levels of the spectrin alphaI/74-kilodalton tryptic peptide.
Blood.
1991;78:1365-1372.
51.
Lorenzo F, Miraglia del Giudice E, Alloisio N, et al.
Severe poikilocytosis associated with a de novo alpha 28 Arg Cys mutation in spectrin.
Br J Haematol.
1993;83:152-157[Medline]
[Order article via Infotrieve].
52.
Perrotta S, Miraglia del Giudice E, Alloisio N, et al.
Mild elliptocytosis associated with the alpha 34 Arg Trp mutation in Genova (alpha I/74).
Blood.
1994;83:3346-3349[Abstract/Free Full Text].
53.
Morle L, Morle F, Roux AF, et al.
Spectrin Tunis (Sp alpha I/78), an elliptocytogenic variant, is due to the CGG TGG condon change (Arg Trp) at position 35 of the alpha I domain.
Blood.
1989;74:828-832[Abstract/Free Full Text].
54.
Lecomte MC, Garbarz M, Grandchamp B, et al.
Sp alpha I/78: a mutation of the alpha I spectrin domain in a white kindred with HE and HPP phenotypes.
Blood.
1989;74:1126-1133[Abstract/Free Full Text].
55.
Perrotta S, Iolascon A, De Angelis F, et al.
Spectrin Anastasia (alpha I/78): a new spectrin variant (alpha 45 Arg Thr) with moderate elliptocytogenic potential.
Br J Haematol.
1995;89:933-936[Medline]
[Order article via Infotrieve].
56.
Morle L, Roux AF, Alloisio N, et al.
Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain: Spectrin Culoz (GGT GTT; alpha I 40 Gly Val) and spectrin Lyon (CTT TTT; alpha I 43 Leu Phe).
J Clin Invest.
1990;86:548-554.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Gaetani, S. Mootien, S. Harper, P. G. Gallagher, and D. W. Speicher
Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site
Blood,
June 15, 2008;
111(12):
5712 - 5720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Peters
Spectrin unfolding mutations: kinks in the links
Blood,
April 15, 2007;
109(8):
3133 - 3134.
[Full Text]
[PDF]
|
 |
|
|
|